Drugs / GSK2340273A
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01236040 | Nov 2010 → Sep 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT01059617 | Feb 2010 → Jan 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT01035749 | Feb → Sep 2010 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00976820 | Oct 2009 → Mar 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00985088 | Oct → Nov 2009 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00985673 | Oct → Dec 2009 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT01051661 | Feb 2010 → Aug 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00979602 | Nov 2009 → Jan 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2340273A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01236040 ↗ |
| Modality | Vaccine | “GSK2340273A-formulation 1 (F1) vaccine” NCT00976820 ↗ |
| Route | Intramuscular | “one or two intramuscular injections” NCT00985088 ↗ |